Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
61
RBZ.V Quote, Financials, Valuation and Earnings
Last price:
$0.53
Seasonality move
:
-11.85%
Day range:
$0.49 - $0.54
52-week range:
$0.06 - $0.69
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
137.07x
Volume:
289.2K
Avg. volume:
226K
1-year change:
657.14%
Market cap:
$20.6M
Revenue:
--
EPS (TTM):
-$0.03
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $56.8K | $41.4K | $56.9K | |
| Other Inc / (Exp) | -- | -- | -- | $66K | -- | |
| Operating Expenses | -- | -- | $582.4K | $720.6K | $234.5K | |
| Operating Income | -- | -- | -$582.4K | -$720.6K | -$234.5K | |
| Net Interest Expenses | -- | -- | -- | -- | $1.6K | |
| EBT. Incl. Unusual Items | -- | -- | -$1.3M | -$654.6K | -$234.9K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -$1.3M | -$654.6K | -$234.9K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$1.3M | -$654.6K | -$234.9K | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.05 | -$0.03 | -$0.01 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.05 | -$0.03 | -$0.01 | |
| Weighted Average Basic Share | -- | -- | $25.2M | $25.5M | $25.9M | |
| Weighted Average Diluted Share | -- | -- | $25.2M | $25.5M | $25.9M | |
| EBITDA | -- | -- | -$582.4K | -$720.6K | -$234.5K | |
| EBIT | -- | -- | -$582.4K | -$720.6K | -$234.5K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -$582.4K | -$720.6K | -$234.5K | |
| Operating Income (Adjusted) | -- | -- | -$582.4K | -$720.6K | -$234.5K | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $7.5K | $9.5K | $50.5K | |
| Other Inc / (Exp) | -- | -- | $4.2K | -- | -- | |
| Operating Expenses | -- | -- | $97.7K | $129.8K | $721.6K | |
| Operating Income | -- | -- | -$97.7K | -$129.8K | -$721.6K | |
| Net Interest Expenses | -- | -- | -- | -- | $100 | |
| EBT. Incl. Unusual Items | -- | -- | -$93.5K | -$129.8K | -$698.3K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -$93.5K | -$129.8K | -$698.3K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$93.5K | -$129.8K | -$698.3K | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.00 | -$0.01 | -$0.02 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.00 | -$0.01 | -$0.02 | |
| Weighted Average Basic Share | -- | $4M | $25.5M | $21.9M | $37.4M | |
| Weighted Average Diluted Share | -- | $4M | $25.5M | $21.9M | $37.4M | |
| EBITDA | -- | -- | -$97.8K | -$129.8K | -$721.6K | |
| EBIT | -- | -- | -$97.8K | -$129.8K | -$721.6K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -$97.7K | -$129.8K | -$721.6K | |
| Operating Income (Adjusted) | -- | -- | -$97.8K | -$129.8K | -$721.6K | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $141.7K | $70.6K | $45.7K | $124.1K | |
| Other Inc / (Exp) | -- | -- | $4.2K | $61.8K | -- | |
| Operating Expenses | -- | $141.7K | $727.6K | $752.1K | $981.6K | |
| Operating Income | -- | -$141.7K | -$727.6K | -$752.1K | -$981.6K | |
| Net Interest Expenses | -- | -- | -- | -- | $2.1K | |
| EBT. Incl. Unusual Items | -- | -$141.8K | -$1.4M | -$623K | -$1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -$623K | -$987.9K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$141.8K | -$1.4M | -$623K | -$1M | |
| Basic EPS (Cont. Ops) | -- | -$0.04 | -$0.09 | -$0.03 | -$0.03 | |
| Diluted EPS (Cont. Ops) | -- | -$0.04 | -$0.09 | -$0.03 | -$0.03 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -$141.7K | -$727.6K | -$752.1K | -$981.6K | |
| EBIT | -- | -$141.7K | -$727.6K | -$752.1K | -$981.6K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$141.7K | -$727.6K | -$752.1K | -$981.6K | |
| Operating Income (Adjusted) | -- | -$141.7K | -$727.6K | -$752.1K | -$981.6K | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $26.3K | $74.1K | $13.9K | $18.2K | $85.4K | |
| Other Inc / (Exp) | -- | -- | $4.2K | -- | -- | |
| Operating Expenses | $26.3K | $74.1K | $158.2K | $189.8K | $901.9K | |
| Operating Income | -$26.3K | -$74.1K | -$158.2K | -$189.8K | -$901.9K | |
| Net Interest Expenses | -- | -- | -- | -- | $500 | |
| EBT. Incl. Unusual Items | -$26.4K | -$74.2K | -$154K | -$122.5K | -$875.4K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$26.4K | -$27.7K | -$154K | -$122.5K | -$875.4K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$26.4K | -$74.2K | -$154K | -$122.5K | -$875.4K | |
| Basic EPS (Cont. Ops) | -$0.01 | -$0.02 | -$0.01 | -$0.01 | -$0.02 | |
| Diluted EPS (Cont. Ops) | -$0.01 | -$0.02 | -$0.01 | -$0.01 | -$0.02 | |
| Weighted Average Basic Share | $5.2M | $12M | $51M | $43.8M | $74.9M | |
| Weighted Average Diluted Share | $5.2M | $12M | $51M | $43.8M | $74.9M | |
| EBITDA | -$26.3K | -$74.1K | -$158.3K | -$189.8K | -$901.9K | |
| EBIT | -$26.3K | -$74.1K | -$158.3K | -$189.8K | -$901.9K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$26.3K | -$74.1K | -$158.2K | -$189.8K | -$901.9K | |
| Operating Income (Adjusted) | -$26.3K | -$74.1K | -$158.3K | -$189.8K | -$901.9K | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $631.8K | $1.4K | $3.6K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | $9.9K | $2.7K | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | $649.3K | $45.2K | $18.2K | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | $698.1K | $117.5K | $108K | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | $66K | -- | -- | |
| Total Current Liabilities | -- | -- | $213.3K | $192.3K | $199.9K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $213.3K | $192.3K | $199.9K | |
| Common Stock | -- | -- | $1.7M | $1.7M | $1.9M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | $484.8K | -$74.8K | -$91.9K | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $484.8K | -$74.8K | -$92K | |
| Total Liabilities and Equity | -- | -- | $698.1K | $117.5K | $107.9K | |
| Cash and Short Terms | -- | -- | $631.8K | $1.4K | $3.6K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $443.5K | $408.8K | $17.2K | $285.6K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $5K | $12.5K | $5.2K | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | $484.1K | $438.9K | $29.7K | $343.6K | |
| Property Plant And Equipment | -- | $15K | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $499.1K | $503.2K | $102K | $528.4K | |
| Accounts Payable | -- | $30.8K | -- | -- | -- | |
| Accrued Expenses | -- | $5.8K | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | $43.4K | $61.8K | -- | -- | |
| Total Current Liabilities | -- | $80K | $157K | $299.3K | $378.3K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $80K | $157K | $299.3K | $378.3K | |
| Common Stock | -- | -- | $1.7M | $1.7M | $2.8M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | $419.2K | $346.2K | -$197.3K | $150.1K | |
| Total Liabilities and Equity | -- | $499.1K | $503.2K | $102K | $528.4K | |
| Cash and Short Terms | -- | $443.5K | $408.8K | $17.2K | $285.6K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$1.3M | -$654.6K | -$234.9K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | $235.5K | $71.5K | $11.7K | |
| Change in Accounts Receivable | -- | -- | -$7.7K | -$33.4K | $31.7K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$453.3K | -$630.4K | -$29.8K | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$162.3K | -- | -$10K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | $798K | -- | -- | |
| Cash From Financing | -- | -- | $798K | -- | $42K | |
| Beginning Cash (CF) | -- | -- | $631.8K | $1.4K | $3.6K | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $182.4K | -$630.4K | $2.2K | |
| Ending Cash (CF) | -- | -- | $814.2K | -$628.9K | $5.7K | |
| Levered Free Cash Flow | -- | -- | -$453.3K | -$630.4K | -$29.8K | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$93.5K | -$129.8K | -$698.3K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | $5.7K | |
| Change in Accounts Receivable | -- | -- | -$4.1K | -$700 | -$31.2K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$80.9K | -$62.1K | -$631.4K | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | $93K | |
| Beginning Cash (CF) | -- | -- | $408.8K | $17.2K | $285.6K | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$80.9K | -$62.1K | -$538.4K | |
| Ending Cash (CF) | -- | -- | $327.9K | -$44.9K | -$252.8K | |
| Levered Free Cash Flow | -- | -- | -$80.9K | -$62.1K | -$631.4K | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$623K | -$987.9K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | $10.2K | -$39.4K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -$458.9K | -$845.2K | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | $67.3K | -$35K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | $1.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$391.6K | $268.4K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -$458.9K | -$845.1K | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$26.4K | -$27.7K | -$154K | -$122.5K | -$875.4K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | $27.9K | |
| Change in Accounts Receivable | -- | -- | -$9.9K | $33.7K | -$37.4K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$13.8K | -$2.8K | -$223K | -$51.5K | -$799.5K | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | $67.3K | -$25K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | $6.7K | -- | -- | $1.1M | |
| Beginning Cash (CF) | $19.4K | $590 | $898.5K | $96.5K | $1.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$13.8K | $3.9K | -$223K | $15.8K | $282K | |
| Ending Cash (CF) | $5.5K | $4.5K | $675.6K | $112.3K | $1.4M | |
| Levered Free Cash Flow | -$13.8K | -$5.1K | -$223K | -$51.5K | -$799.5K | |
Get RBZ.V Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
RBZ.V
Sector
P/E ratio
--
--
PEG ratio
-1.11x
--
P/B ratio
137.07x
--
Price / LTM sales
--
--
Growth Metrics
RBZ.V
Sector
Revenue growth
--
--
Earnings growth
-216.95%
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
RBZ.V
Sector
Profitability FY 2025
--
--
Return on invested capital
-865.84%
--
Return on assets
-273.18%
--
Return on equity
-989.84%
--
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
Feb
10
Estimated Next Earnings Date
May
12
Balance Sheet
RBZ.V
Sector
Total cash
$285.6K
--
Short term investments
--
--
Total assets
$108K
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
67
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
33
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
